nodes	percent_of_prediction	percent_of_DWPC	metapath
Clotrimazole—CYP11A1—Cholecalciferol—psoriasis	0.077	0.101	CbGbCtD
Clotrimazole—CYP11B1—Hydrocortisone—psoriasis	0.0641	0.0838	CbGbCtD
Clotrimazole—CYP17A1—Dexamethasone—psoriasis	0.0398	0.0521	CbGbCtD
Clotrimazole—CYP2A6—Methoxsalen—psoriasis	0.0343	0.0448	CbGbCtD
Clotrimazole—ABCC3—Cyclosporine—psoriasis	0.0336	0.044	CbGbCtD
Clotrimazole—CYP11A1—Dexamethasone—psoriasis	0.0333	0.0436	CbGbCtD
Clotrimazole—CYP19A1—Betamethasone—psoriasis	0.0267	0.0349	CbGbCtD
Clotrimazole—CYP2C8—Tazarotene—psoriasis	0.0262	0.0343	CbGbCtD
Clotrimazole—CYP1A2—Clobetasol propionate—psoriasis	0.0249	0.0326	CbGbCtD
Clotrimazole—ABCC2—Mycophenolate mofetil—psoriasis	0.0202	0.0264	CbGbCtD
Clotrimazole—ABCC3—Methotrexate—psoriasis	0.0178	0.0233	CbGbCtD
Clotrimazole—CYP2A6—Prednisolone—psoriasis	0.0167	0.0218	CbGbCtD
Clotrimazole—CYP19A1—Dexamethasone—psoriasis	0.0155	0.0203	CbGbCtD
Clotrimazole—ABCC2—Cyclosporine—psoriasis	0.0153	0.02	CbGbCtD
Clotrimazole—CYP2B6—Cholecalciferol—psoriasis	0.0148	0.0193	CbGbCtD
Clotrimazole—CYP1A2—Methoxsalen—psoriasis	0.0131	0.0171	CbGbCtD
Clotrimazole—CYP2D6—Hydroxyurea—psoriasis	0.0118	0.0154	CbGbCtD
Clotrimazole—CYP2C8—Cholecalciferol—psoriasis	0.0112	0.0146	CbGbCtD
Clotrimazole—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0108	0.0141	CbGbCtD
Clotrimazole—CYP3A7—Hydrocortisone—psoriasis	0.0108	0.0141	CbGbCtD
Clotrimazole—CYP3A7—Cyclosporine—psoriasis	0.0102	0.0133	CbGbCtD
Clotrimazole—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0102	0.0133	CbGbCtD
Clotrimazole—ABCC2—Dexamethasone—psoriasis	0.0101	0.0132	CbGbCtD
Clotrimazole—CYP2A6—Dexamethasone—psoriasis	0.00983	0.0129	CbGbCtD
Clotrimazole—CYP2C8—Mycophenolate mofetil—psoriasis	0.00971	0.0127	CbGbCtD
Clotrimazole—CYP2C19—Cholecalciferol—psoriasis	0.0094	0.0123	CbGbCtD
Clotrimazole—CYP3A4—Calcitriol—psoriasis	0.00882	0.0115	CbGbCtD
Clotrimazole—ABCC2—Methotrexate—psoriasis	0.00809	0.0106	CbGbCtD
Clotrimazole—CYP2C9—Cholecalciferol—psoriasis	0.00781	0.0102	CbGbCtD
Clotrimazole—CYP2C8—Hydrocortisone—psoriasis	0.00779	0.0102	CbGbCtD
Clotrimazole—CYP2C8—Cyclosporine—psoriasis	0.00736	0.00962	CbGbCtD
Clotrimazole—CYP2D6—Cholecalciferol—psoriasis	0.00714	0.00934	CbGbCtD
Clotrimazole—CYP3A4—Methoxsalen—psoriasis	0.00686	0.00897	CbGbCtD
Clotrimazole—CYP3A7—Dexamethasone—psoriasis	0.00672	0.00879	CbGbCtD
Clotrimazole—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00672	0.00879	CbGbCtD
Clotrimazole—ABCB1—Mycophenolate mofetil—psoriasis	0.00657	0.00859	CbGbCtD
Clotrimazole—CYP2C19—Prednisone—psoriasis	0.00651	0.00852	CbGbCtD
Clotrimazole—CYP2E1—Dexamethasone—psoriasis	0.00649	0.00848	CbGbCtD
Clotrimazole—CYP2B6—Dexamethasone—psoriasis	0.0064	0.00837	CbGbCtD
Clotrimazole—CYP2C19—Cyclosporine—psoriasis	0.00617	0.00807	CbGbCtD
Clotrimazole—ABCB1—Betamethasone—psoriasis	0.00564	0.00737	CbGbCtD
Clotrimazole—ABCB1—Prednisolone—psoriasis	0.00556	0.00728	CbGbCtD
Clotrimazole—ABCB1—Hydrocortisone—psoriasis	0.00527	0.0069	CbGbCtD
Clotrimazole—ABCB1—Prednisone—psoriasis	0.00525	0.00687	CbGbCtD
Clotrimazole—CYP2C9—Cyclosporine—psoriasis	0.00513	0.00671	CbGbCtD
Clotrimazole—ABCB1—Cyclosporine—psoriasis	0.00498	0.00651	CbGbCtD
Clotrimazole—CYP2C8—Dexamethasone—psoriasis	0.00485	0.00634	CbGbCtD
Clotrimazole—CYP2D6—Cyclosporine—psoriasis	0.00469	0.00614	CbGbCtD
Clotrimazole—CYP3A4—Cholecalciferol—psoriasis	0.00454	0.00594	CbGbCtD
Clotrimazole—CYP2C19—Dexamethasone—psoriasis	0.00407	0.00532	CbGbCtD
Clotrimazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.00394	0.00515	CbGbCtD
Clotrimazole—CYP3A4—Triamcinolone—psoriasis	0.00394	0.00515	CbGbCtD
Clotrimazole—CYP2C9—Dexamethasone—psoriasis	0.00338	0.00442	CbGbCtD
Clotrimazole—CYP3A4—Betamethasone—psoriasis	0.00338	0.00442	CbGbCtD
Clotrimazole—CYP3A4—Prednisolone—psoriasis	0.00333	0.00436	CbGbCtD
Clotrimazole—ABCB1—Dexamethasone—psoriasis	0.00328	0.00429	CbGbCtD
Clotrimazole—CYP3A4—Hydrocortisone—psoriasis	0.00316	0.00413	CbGbCtD
Clotrimazole—CYP3A4—Prednisone—psoriasis	0.00315	0.00412	CbGbCtD
Clotrimazole—CYP2D6—Dexamethasone—psoriasis	0.00309	0.00404	CbGbCtD
Clotrimazole—CYP3A4—Cyclosporine—psoriasis	0.00298	0.0039	CbGbCtD
Clotrimazole—Skin irritation—Acitretin—psoriasis	0.00265	0.016	CcSEcCtD
Clotrimazole—Skin irritation—Fluocinolone Acetonide—psoriasis	0.00264	0.016	CcSEcCtD
Clotrimazole—ABCB1—Methotrexate—psoriasis	0.00264	0.00345	CbGbCtD
Clotrimazole—Stinging—Clobetasol propionate—psoriasis	0.00251	0.0151	CcSEcCtD
Clotrimazole—Skin exfoliation—Tazarotene—psoriasis	0.00229	0.0138	CcSEcCtD
Clotrimazole—Redness—Methoxsalen—psoriasis	0.00214	0.0129	CcSEcCtD
Clotrimazole—Blister—Methoxsalen—psoriasis	0.00201	0.0121	CcSEcCtD
Clotrimazole—CYP3A4—Dexamethasone—psoriasis	0.00197	0.00257	CbGbCtD
Clotrimazole—Redness—Calcitriol—psoriasis	0.00191	0.0115	CcSEcCtD
Clotrimazole—Abdominal cramps—Calcitriol—psoriasis	0.00191	0.0115	CcSEcCtD
Clotrimazole—Localized exfoliation—Triamcinolone—psoriasis	0.00189	0.0115	CcSEcCtD
Clotrimazole—Dermatitis bullous—Tazarotene—psoriasis	0.00182	0.011	CcSEcCtD
Clotrimazole—Blister—Calcitriol—psoriasis	0.00179	0.0108	CcSEcCtD
Clotrimazole—Skin exfoliation—Fluocinonide—psoriasis	0.00175	0.0106	CcSEcCtD
Clotrimazole—Redness—Acitretin—psoriasis	0.0017	0.0103	CcSEcCtD
Clotrimazole—Erythema—Calcipotriol—psoriasis	0.00142	0.00858	CcSEcCtD
Clotrimazole—Skin exfoliation—Methoxsalen—psoriasis	0.00138	0.00834	CcSEcCtD
Clotrimazole—Skin irritation—Hydrocortisone—psoriasis	0.00125	0.00757	CcSEcCtD
Clotrimazole—Blister—Hydroxyurea—psoriasis	0.00125	0.00755	CcSEcCtD
Clotrimazole—Haemoglobin—Tazarotene—psoriasis	0.00121	0.00731	CcSEcCtD
Clotrimazole—Haemorrhage—Tazarotene—psoriasis	0.0012	0.00727	CcSEcCtD
Clotrimazole—Dermatitis bullous—Methoxsalen—psoriasis	0.0011	0.00664	CcSEcCtD
Clotrimazole—Skin exfoliation—Acitretin—psoriasis	0.00109	0.00661	CcSEcCtD
Clotrimazole—Erythema—Tazarotene—psoriasis	0.00105	0.00633	CcSEcCtD
Clotrimazole—Pain—Calcipotriol—psoriasis	0.000991	0.00599	CcSEcCtD
Clotrimazole—Dermatitis bullous—Calcitriol—psoriasis	0.000979	0.00592	CcSEcCtD
Clotrimazole—Erythema—Clobetasol propionate—psoriasis	0.000888	0.00537	CcSEcCtD
Clotrimazole—Burning sensation—Cyclosporine—psoriasis	0.000878	0.0053	CcSEcCtD
Clotrimazole—Dermatitis bullous—Acitretin—psoriasis	0.000871	0.00526	CcSEcCtD
Clotrimazole—Skin exfoliation—Hydroxyurea—psoriasis	0.000859	0.00519	CcSEcCtD
Clotrimazole—Oedema—Tazarotene—psoriasis	0.000855	0.00516	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Calcitriol—psoriasis	0.000842	0.00509	CcSEcCtD
Clotrimazole—Redness—Hydrocortisone—psoriasis	0.000803	0.00485	CcSEcCtD
Clotrimazole—Erythema—Fluocinonide—psoriasis	0.000801	0.00484	CcSEcCtD
Clotrimazole—Blister—Prednisolone—psoriasis	0.00077	0.00465	CcSEcCtD
Clotrimazole—Liver function test abnormal—Acitretin—psoriasis	0.000768	0.00464	CcSEcCtD
Clotrimazole—Stinging—Cyclosporine—psoriasis	0.000753	0.00455	CcSEcCtD
Clotrimazole—Rash—Calcipotriol—psoriasis	0.000731	0.00442	CcSEcCtD
Clotrimazole—Pain—Tazarotene—psoriasis	0.000731	0.00442	CcSEcCtD
Clotrimazole—Dermatitis—Calcipotriol—psoriasis	0.00073	0.00441	CcSEcCtD
Clotrimazole—Blister—Triamcinolone—psoriasis	0.000708	0.00428	CcSEcCtD
Clotrimazole—Stinging—Prednisolone—psoriasis	0.000685	0.00414	CcSEcCtD
Clotrimazole—Dermatitis bullous—Hydroxyurea—psoriasis	0.000684	0.00413	CcSEcCtD
Clotrimazole—Bladder pain—Mycophenolic acid—psoriasis	0.000682	0.00412	CcSEcCtD
Clotrimazole—Stinging—Hydrocortisone—psoriasis	0.000669	0.00404	CcSEcCtD
Clotrimazole—Haemoglobin—Calcitriol—psoriasis	0.00065	0.00393	CcSEcCtD
Clotrimazole—Haemorrhage—Calcitriol—psoriasis	0.000647	0.00391	CcSEcCtD
Clotrimazole—Blister—Betamethasone—psoriasis	0.000642	0.00388	CcSEcCtD
Clotrimazole—Blister—Dexamethasone—psoriasis	0.000642	0.00388	CcSEcCtD
Clotrimazole—Erythema—Methoxsalen—psoriasis	0.000632	0.00382	CcSEcCtD
Clotrimazole—Stinging—Triamcinolone—psoriasis	0.00063	0.00381	CcSEcCtD
Clotrimazole—Pain—Clobetasol propionate—psoriasis	0.00062	0.00374	CcSEcCtD
Clotrimazole—Muscle spasms—Methoxsalen—psoriasis	0.000608	0.00367	CcSEcCtD
Clotrimazole—Cystitis noninfective—Mycophenolate mofetil—psoriasis	0.000581	0.00351	CcSEcCtD
Clotrimazole—Haemoglobin—Acitretin—psoriasis	0.000579	0.0035	CcSEcCtD
Clotrimazole—Haemorrhage—Acitretin—psoriasis	0.000576	0.00348	CcSEcCtD
Clotrimazole—Cystitis—Mycophenolate mofetil—psoriasis	0.000574	0.00347	CcSEcCtD
Clotrimazole—Dermatitis bullous—Mycophenolic acid—psoriasis	0.000573	0.00346	CcSEcCtD
Clotrimazole—Stinging—Betamethasone—psoriasis	0.000572	0.00345	CcSEcCtD
Clotrimazole—Stinging—Dexamethasone—psoriasis	0.000572	0.00345	CcSEcCtD
Clotrimazole—Pain—Beclomethasone—psoriasis	0.000564	0.00341	CcSEcCtD
Clotrimazole—Erythema—Calcitriol—psoriasis	0.000563	0.0034	CcSEcCtD
Clotrimazole—Pain—Fluocinonide—psoriasis	0.000559	0.00338	CcSEcCtD
Clotrimazole—Rash—Tazarotene—psoriasis	0.000539	0.00326	CcSEcCtD
Clotrimazole—Dermatitis—Tazarotene—psoriasis	0.000538	0.00325	CcSEcCtD
Clotrimazole—Bladder pain—Mycophenolate mofetil—psoriasis	0.000538	0.00325	CcSEcCtD
Clotrimazole—Urticaria—Beclomethasone—psoriasis	0.000524	0.00317	CcSEcCtD
Clotrimazole—Skin exfoliation—Hydrocortisone—psoriasis	0.000517	0.00313	CcSEcCtD
Clotrimazole—Oedema—Methoxsalen—psoriasis	0.000516	0.00312	CcSEcCtD
Clotrimazole—Liver function test abnormal—Mycophenolic acid—psoriasis	0.000505	0.00305	CcSEcCtD
Clotrimazole—Erythema—Acitretin—psoriasis	0.000501	0.00303	CcSEcCtD
Clotrimazole—Erythema—Fluocinolone Acetonide—psoriasis	0.0005	0.00302	CcSEcCtD
Clotrimazole—Cramp muscle—Mycophenolic acid—psoriasis	0.000493	0.00298	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Mycophenolic acid—psoriasis	0.000493	0.00298	CcSEcCtD
Clotrimazole—Skin exfoliation—Triamcinolone—psoriasis	0.000487	0.00294	CcSEcCtD
Clotrimazole—Burning sensation—Methotrexate—psoriasis	0.000485	0.00293	CcSEcCtD
Clotrimazole—Muscle spasms—Acitretin—psoriasis	0.000482	0.00291	CcSEcCtD
Clotrimazole—Abdominal distension—Mycophenolic acid—psoriasis	0.000476	0.00288	CcSEcCtD
Clotrimazole—Dermatitis bullous—Cyclosporine—psoriasis	0.000463	0.0028	CcSEcCtD
Clotrimazole—Rash—Clobetasol propionate—psoriasis	0.000457	0.00276	CcSEcCtD
Clotrimazole—Dermatitis—Clobetasol propionate—psoriasis	0.000456	0.00276	CcSEcCtD
Clotrimazole—Haemoglobin—Hydroxyurea—psoriasis	0.000454	0.00275	CcSEcCtD
Clotrimazole—Haemorrhage—Hydroxyurea—psoriasis	0.000452	0.00273	CcSEcCtD
Clotrimazole—Dermatitis bullous—Mycophenolate mofetil—psoriasis	0.000452	0.00273	CcSEcCtD
Clotrimazole—Skin exfoliation—Betamethasone—psoriasis	0.000442	0.00267	CcSEcCtD
Clotrimazole—Skin exfoliation—Dexamethasone—psoriasis	0.000442	0.00267	CcSEcCtD
Clotrimazole—Pollakiuria—Mycophenolic acid—psoriasis	0.000437	0.00264	CcSEcCtD
Clotrimazole—Dermatitis bullous—Prednisolone—psoriasis	0.000422	0.00255	CcSEcCtD
Clotrimazole—Rash—Beclomethasone—psoriasis	0.000416	0.00251	CcSEcCtD
Clotrimazole—Dermatitis—Beclomethasone—psoriasis	0.000416	0.00251	CcSEcCtD
Clotrimazole—Rash—Fluocinonide—psoriasis	0.000412	0.00249	CcSEcCtD
Clotrimazole—Dermatitis—Fluocinonide—psoriasis	0.000412	0.00249	CcSEcCtD
Clotrimazole—Urticaria—Methoxsalen—psoriasis	0.00041	0.00248	CcSEcCtD
Clotrimazole—Oedema—Acitretin—psoriasis	0.000409	0.00247	CcSEcCtD
Clotrimazole—Oedema—Fluocinolone Acetonide—psoriasis	0.000408	0.00246	CcSEcCtD
Clotrimazole—Liver function test abnormal—Mycophenolate mofetil—psoriasis	0.000399	0.00241	CcSEcCtD
Clotrimazole—Cramp muscle—Cyclosporine—psoriasis	0.000399	0.00241	CcSEcCtD
Clotrimazole—Erythema—Hydroxyurea—psoriasis	0.000393	0.00238	CcSEcCtD
Clotrimazole—Pain—Calcitriol—psoriasis	0.000393	0.00238	CcSEcCtD
Clotrimazole—Nausea—Beclomethasone—psoriasis	0.000392	0.00237	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Mycophenolate mofetil—psoriasis	0.000389	0.00235	CcSEcCtD
Clotrimazole—Dermatitis bullous—Triamcinolone—psoriasis	0.000388	0.00234	CcSEcCtD
Clotrimazole—Abdominal distension—Cyclosporine—psoriasis	0.000385	0.00233	CcSEcCtD
Clotrimazole—Skin exfoliation—Prednisone—psoriasis	0.000385	0.00233	CcSEcCtD
Clotrimazole—Haemoglobin—Mycophenolic acid—psoriasis	0.00038	0.0023	CcSEcCtD
Clotrimazole—Haemorrhage—Mycophenolic acid—psoriasis	0.000379	0.00229	CcSEcCtD
Clotrimazole—Abdominal distension—Mycophenolate mofetil—psoriasis	0.000376	0.00227	CcSEcCtD
Clotrimazole—Urticaria—Calcitriol—psoriasis	0.000365	0.00221	CcSEcCtD
Clotrimazole—Abdominal pain—Calcitriol—psoriasis	0.000363	0.0022	CcSEcCtD
Clotrimazole—Pollakiuria—Cyclosporine—psoriasis	0.000353	0.00214	CcSEcCtD
Clotrimazole—Dermatitis bullous—Dexamethasone—psoriasis	0.000352	0.00213	CcSEcCtD
Clotrimazole—Dermatitis bullous—Betamethasone—psoriasis	0.000352	0.00213	CcSEcCtD
Clotrimazole—Abdominal distension—Prednisolone—psoriasis	0.000351	0.00212	CcSEcCtD
Clotrimazole—Pain—Acitretin—psoriasis	0.00035	0.00211	CcSEcCtD
Clotrimazole—Pain—Fluocinolone Acetonide—psoriasis	0.000349	0.00211	CcSEcCtD
Clotrimazole—Pollakiuria—Mycophenolate mofetil—psoriasis	0.000345	0.00208	CcSEcCtD
Clotrimazole—Abdominal distension—Hydrocortisone—psoriasis	0.000342	0.00207	CcSEcCtD
Clotrimazole—Cystitis noninfective—Methotrexate—psoriasis	0.000329	0.00199	CcSEcCtD
Clotrimazole—Cystitis—Methotrexate—psoriasis	0.000325	0.00197	CcSEcCtD
Clotrimazole—Rash—Methoxsalen—psoriasis	0.000325	0.00197	CcSEcCtD
Clotrimazole—Dermatitis—Methoxsalen—psoriasis	0.000325	0.00196	CcSEcCtD
Clotrimazole—Urticaria—Acitretin—psoriasis	0.000325	0.00196	CcSEcCtD
Clotrimazole—Flatulence—Mycophenolic acid—psoriasis	0.000325	0.00196	CcSEcCtD
Clotrimazole—Abdominal pain—Acitretin—psoriasis	0.000323	0.00195	CcSEcCtD
Clotrimazole—Abdominal distension—Triamcinolone—psoriasis	0.000322	0.00195	CcSEcCtD
Clotrimazole—Skin exfoliation—Methotrexate—psoriasis	0.000322	0.00194	CcSEcCtD
Clotrimazole—Oedema—Hydroxyurea—psoriasis	0.000321	0.00194	CcSEcCtD
Clotrimazole—Muscle spasms—Mycophenolic acid—psoriasis	0.000317	0.00191	CcSEcCtD
Clotrimazole—Haemoglobin—Cyclosporine—psoriasis	0.000308	0.00186	CcSEcCtD
Clotrimazole—Nausea—Methoxsalen—psoriasis	0.000306	0.00185	CcSEcCtD
Clotrimazole—Haemorrhage—Cyclosporine—psoriasis	0.000306	0.00185	CcSEcCtD
Clotrimazole—Bladder pain—Methotrexate—psoriasis	0.000305	0.00184	CcSEcCtD
Clotrimazole—Haemoglobin—Mycophenolate mofetil—psoriasis	0.0003	0.00181	CcSEcCtD
Clotrimazole—Haemorrhage—Mycophenolate mofetil—psoriasis	0.000299	0.00181	CcSEcCtD
Clotrimazole—Vomiting—Calcitriol—psoriasis	0.000292	0.00177	CcSEcCtD
Clotrimazole—Rash—Calcitriol—psoriasis	0.00029	0.00175	CcSEcCtD
Clotrimazole—Dermatitis—Calcitriol—psoriasis	0.00029	0.00175	CcSEcCtD
Clotrimazole—Haemoglobin—Prednisolone—psoriasis	0.00028	0.00169	CcSEcCtD
Clotrimazole—CYP19A1—Biological oxidations—CYP2S1—psoriasis	0.00028	0.00401	CbGpPWpGaD
Clotrimazole—Haemorrhage—Prednisolone—psoriasis	0.000279	0.00168	CcSEcCtD
Clotrimazole—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000276	0.00395	CbGpPWpGaD
Clotrimazole—Pain—Hydroxyurea—psoriasis	0.000275	0.00166	CcSEcCtD
Clotrimazole—Haemoglobin—Hydrocortisone—psoriasis	0.000274	0.00165	CcSEcCtD
Clotrimazole—Nausea—Calcitriol—psoriasis	0.000273	0.00165	CcSEcCtD
Clotrimazole—Haemorrhage—Hydrocortisone—psoriasis	0.000272	0.00164	CcSEcCtD
Clotrimazole—Oedema—Mycophenolic acid—psoriasis	0.000269	0.00163	CcSEcCtD
Clotrimazole—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000264	0.00379	CbGpPWpGaD
Clotrimazole—Flatulence—Cyclosporine—psoriasis	0.000263	0.00159	CcSEcCtD
Clotrimazole—Vomiting—Acitretin—psoriasis	0.00026	0.00157	CcSEcCtD
Clotrimazole—Vomiting—Fluocinolone Acetonide—psoriasis	0.000259	0.00157	CcSEcCtD
Clotrimazole—Rash—Acitretin—psoriasis	0.000258	0.00156	CcSEcCtD
Clotrimazole—Dermatitis—Acitretin—psoriasis	0.000258	0.00156	CcSEcCtD
Clotrimazole—Haemoglobin—Triamcinolone—psoriasis	0.000258	0.00156	CcSEcCtD
Clotrimazole—Rash—Fluocinolone Acetonide—psoriasis	0.000257	0.00155	CcSEcCtD
Clotrimazole—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000257	0.00155	CcSEcCtD
Clotrimazole—Muscle spasms—Cyclosporine—psoriasis	0.000256	0.00155	CcSEcCtD
Clotrimazole—Haemorrhage—Triamcinolone—psoriasis	0.000256	0.00155	CcSEcCtD
Clotrimazole—Flatulence—Mycophenolate mofetil—psoriasis	0.000256	0.00155	CcSEcCtD
Clotrimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000255	0.00366	CbGpPWpGaD
Clotrimazole—Abdominal distension—Prednisone—psoriasis	0.000255	0.00154	CcSEcCtD
Clotrimazole—Muscle spasms—Mycophenolate mofetil—psoriasis	0.00025	0.00151	CcSEcCtD
Clotrimazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000246	0.00353	CbGpPWpGaD
Clotrimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000245	0.00352	CbGpPWpGaD
Clotrimazole—Nausea—Acitretin—psoriasis	0.000243	0.00147	CcSEcCtD
Clotrimazole—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000243	0.00348	CbGpPWpGaD
Clotrimazole—Erythema—Prednisolone—psoriasis	0.000243	0.00147	CcSEcCtD
Clotrimazole—Nausea—Fluocinolone Acetonide—psoriasis	0.000242	0.00146	CcSEcCtD
Clotrimazole—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000242	0.00347	CbGpPWpGaD
Clotrimazole—CYP19A1—Tryptophan metabolism—CAT—psoriasis	0.000241	0.00346	CbGpPWpGaD
Clotrimazole—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000239	0.00343	CbGpPWpGaD
Clotrimazole—Erythema—Hydrocortisone—psoriasis	0.000237	0.00143	CcSEcCtD
Clotrimazole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000235	0.00337	CbGpPWpGaD
Clotrimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000235	0.00337	CbGpPWpGaD
Clotrimazole—Haemoglobin—Betamethasone—psoriasis	0.000234	0.00141	CcSEcCtD
Clotrimazole—Haemoglobin—Dexamethasone—psoriasis	0.000234	0.00141	CcSEcCtD
Clotrimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000233	0.00334	CbGpPWpGaD
Clotrimazole—Haemorrhage—Dexamethasone—psoriasis	0.000233	0.00141	CcSEcCtD
Clotrimazole—Haemorrhage—Betamethasone—psoriasis	0.000233	0.00141	CcSEcCtD
Clotrimazole—Pain—Mycophenolic acid—psoriasis	0.00023	0.00139	CcSEcCtD
Clotrimazole—CYP51A1—SREBP signalling—PPARG—psoriasis	0.000229	0.00328	CbGpPWpGaD
Clotrimazole—Liver function test abnormal—Methotrexate—psoriasis	0.000226	0.00136	CcSEcCtD
Clotrimazole—Erythema—Triamcinolone—psoriasis	0.000223	0.00135	CcSEcCtD
Clotrimazole—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000222	0.00319	CbGpPWpGaD
Clotrimazole—Oedema—Cyclosporine—psoriasis	0.000218	0.00131	CcSEcCtD
Clotrimazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000214	0.00308	CbGpPWpGaD
Clotrimazole—Abdominal pain—Mycophenolic acid—psoriasis	0.000213	0.00128	CcSEcCtD
Clotrimazole—Oedema—Mycophenolate mofetil—psoriasis	0.000212	0.00128	CcSEcCtD
Clotrimazole—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000209	0.003	CbGpPWpGaD
Clotrimazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000206	0.00296	CbGpPWpGaD
Clotrimazole—Vomiting—Hydroxyurea—psoriasis	0.000204	0.00123	CcSEcCtD
Clotrimazole—Haemoglobin—Prednisone—psoriasis	0.000204	0.00123	CcSEcCtD
Clotrimazole—Haemorrhage—Prednisone—psoriasis	0.000203	0.00122	CcSEcCtD
Clotrimazole—Rash—Hydroxyurea—psoriasis	0.000202	0.00122	CcSEcCtD
Clotrimazole—Erythema—Betamethasone—psoriasis	0.000202	0.00122	CcSEcCtD
Clotrimazole—Erythema—Dexamethasone—psoriasis	0.000202	0.00122	CcSEcCtD
Clotrimazole—Dermatitis—Hydroxyurea—psoriasis	0.000202	0.00122	CcSEcCtD
Clotrimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000199	0.00285	CbGpPWpGaD
Clotrimazole—Oedema—Prednisolone—psoriasis	0.000198	0.0012	CcSEcCtD
Clotrimazole—ABCC3—NRF2 pathway—TGFA—psoriasis	0.000198	0.00284	CbGpPWpGaD
Clotrimazole—Oedema—Hydrocortisone—psoriasis	0.000193	0.00117	CcSEcCtD
Clotrimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000191	0.00275	CbGpPWpGaD
Clotrimazole—Nausea—Hydroxyurea—psoriasis	0.000191	0.00115	CcSEcCtD
Clotrimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000189	0.00272	CbGpPWpGaD
Clotrimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000188	0.00269	CbGpPWpGaD
Clotrimazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000187	0.00269	CbGpPWpGaD
Clotrimazole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000187	0.00268	CbGpPWpGaD
Clotrimazole—Pain—Cyclosporine—psoriasis	0.000186	0.00112	CcSEcCtD
Clotrimazole—Oedema—Triamcinolone—psoriasis	0.000182	0.0011	CcSEcCtD
Clotrimazole—Pain—Mycophenolate mofetil—psoriasis	0.000182	0.0011	CcSEcCtD
Clotrimazole—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.00018	0.00257	CbGpPWpGaD
Clotrimazole—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000177	0.00254	CbGpPWpGaD
Clotrimazole—CYP11B1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000177	0.00254	CbGpPWpGaD
Clotrimazole—Erythema—Prednisone—psoriasis	0.000176	0.00107	CcSEcCtD
Clotrimazole—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000176	0.00252	CbGpPWpGaD
Clotrimazole—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000173	0.00249	CbGpPWpGaD
Clotrimazole—Urticaria—Cyclosporine—psoriasis	0.000173	0.00104	CcSEcCtD
Clotrimazole—Abdominal pain—Cyclosporine—psoriasis	0.000172	0.00104	CcSEcCtD
Clotrimazole—Vomiting—Mycophenolic acid—psoriasis	0.000171	0.00103	CcSEcCtD
Clotrimazole—Haemoglobin—Methotrexate—psoriasis	0.00017	0.00103	CcSEcCtD
Clotrimazole—Rash—Mycophenolic acid—psoriasis	0.00017	0.00102	CcSEcCtD
Clotrimazole—Dermatitis—Mycophenolic acid—psoriasis	0.000169	0.00102	CcSEcCtD
Clotrimazole—Pain—Prednisolone—psoriasis	0.000169	0.00102	CcSEcCtD
Clotrimazole—Haemorrhage—Methotrexate—psoriasis	0.000169	0.00102	CcSEcCtD
Clotrimazole—Urticaria—Mycophenolate mofetil—psoriasis	0.000169	0.00102	CcSEcCtD
Clotrimazole—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000168	0.00101	CcSEcCtD
Clotrimazole—Pain—Hydrocortisone—psoriasis	0.000165	0.000999	CcSEcCtD
Clotrimazole—Oedema—Dexamethasone—psoriasis	0.000165	0.000998	CcSEcCtD
Clotrimazole—Oedema—Betamethasone—psoriasis	0.000165	0.000998	CcSEcCtD
Clotrimazole—Nausea—Mycophenolic acid—psoriasis	0.00016	0.000965	CcSEcCtD
Clotrimazole—Urticaria—Prednisolone—psoriasis	0.000157	0.000951	CcSEcCtD
Clotrimazole—ABCC2—NRF2 pathway—TGFA—psoriasis	0.000157	0.00225	CbGpPWpGaD
Clotrimazole—Pain—Triamcinolone—psoriasis	0.000156	0.000941	CcSEcCtD
Clotrimazole—Urticaria—Hydrocortisone—psoriasis	0.000154	0.000928	CcSEcCtD
Clotrimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000154	0.0022	CbGpPWpGaD
Clotrimazole—Abdominal pain—Hydrocortisone—psoriasis	0.000153	0.000924	CcSEcCtD
Clotrimazole—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000152	0.00218	CbGpPWpGaD
Clotrimazole—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000152	0.00218	CbGpPWpGaD
Clotrimazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000151	0.00217	CbGpPWpGaD
Clotrimazole—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000151	0.00217	CbGpPWpGaD
Clotrimazole—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.00015	0.00215	CbGpPWpGaD
Clotrimazole—Erythema—Methotrexate—psoriasis	0.000147	0.00089	CcSEcCtD
Clotrimazole—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000146	0.00209	CbGpPWpGaD
Clotrimazole—Urticaria—Triamcinolone—psoriasis	0.000145	0.000874	CcSEcCtD
Clotrimazole—Oedema—Prednisone—psoriasis	0.000144	0.000869	CcSEcCtD
Clotrimazole—Pain—Dexamethasone—psoriasis	0.000141	0.000854	CcSEcCtD
Clotrimazole—Pain—Betamethasone—psoriasis	0.000141	0.000854	CcSEcCtD
Clotrimazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000141	0.00203	CbGpPWpGaD
Clotrimazole—Vomiting—Cyclosporine—psoriasis	0.000138	0.000836	CcSEcCtD
Clotrimazole—Rash—Cyclosporine—psoriasis	0.000137	0.000829	CcSEcCtD
Clotrimazole—Dermatitis—Cyclosporine—psoriasis	0.000137	0.000828	CcSEcCtD
Clotrimazole—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000136	0.00195	CbGpPWpGaD
Clotrimazole—Vomiting—Mycophenolate mofetil—psoriasis	0.000135	0.000816	CcSEcCtD
Clotrimazole—Rash—Mycophenolate mofetil—psoriasis	0.000134	0.000809	CcSEcCtD
Clotrimazole—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000134	0.00192	CbGpPWpGaD
Clotrimazole—Dermatitis—Mycophenolate mofetil—psoriasis	0.000134	0.000808	CcSEcCtD
Clotrimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000133	0.00191	CbGpPWpGaD
Clotrimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000132	0.00189	CbGpPWpGaD
Clotrimazole—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000132	0.00189	CbGpPWpGaD
Clotrimazole—Urticaria—Dexamethasone—psoriasis	0.000131	0.000793	CcSEcCtD
Clotrimazole—Urticaria—Betamethasone—psoriasis	0.000131	0.000793	CcSEcCtD
Clotrimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000131	0.00187	CbGpPWpGaD
Clotrimazole—Abdominal pain—Betamethasone—psoriasis	0.000131	0.000789	CcSEcCtD
Clotrimazole—Abdominal pain—Dexamethasone—psoriasis	0.000131	0.000789	CcSEcCtD
Clotrimazole—Nausea—Cyclosporine—psoriasis	0.000129	0.000781	CcSEcCtD
Clotrimazole—ABCC3—Fluoropyrimidine Activity—TP53—psoriasis	0.000127	0.00182	CbGpPWpGaD
Clotrimazole—CYP11B1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000126	0.00181	CbGpPWpGaD
Clotrimazole—Nausea—Mycophenolate mofetil—psoriasis	0.000126	0.000762	CcSEcCtD
Clotrimazole—Rash—Prednisolone—psoriasis	0.000125	0.000754	CcSEcCtD
Clotrimazole—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000125	0.00179	CbGpPWpGaD
Clotrimazole—Dermatitis—Prednisolone—psoriasis	0.000125	0.000754	CcSEcCtD
Clotrimazole—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000124	0.00178	CbGpPWpGaD
Clotrimazole—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000124	0.00177	CbGpPWpGaD
Clotrimazole—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000123	0.00176	CbGpPWpGaD
Clotrimazole—Vomiting—Hydrocortisone—psoriasis	0.000123	0.000743	CcSEcCtD
Clotrimazole—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000122	0.00175	CbGpPWpGaD
Clotrimazole—Rash—Hydrocortisone—psoriasis	0.000122	0.000737	CcSEcCtD
Clotrimazole—Dermatitis—Hydrocortisone—psoriasis	0.000122	0.000736	CcSEcCtD
Clotrimazole—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000121	0.00173	CbGpPWpGaD
Clotrimazole—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.00012	0.00172	CbGpPWpGaD
Clotrimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000118	0.00169	CbGpPWpGaD
Clotrimazole—Nausea—Prednisolone—psoriasis	0.000118	0.000711	CcSEcCtD
Clotrimazole—Vomiting—Triamcinolone—psoriasis	0.000116	0.0007	CcSEcCtD
Clotrimazole—Nausea—Hydrocortisone—psoriasis	0.000115	0.000694	CcSEcCtD
Clotrimazole—Rash—Triamcinolone—psoriasis	0.000115	0.000694	CcSEcCtD
Clotrimazole—Dermatitis—Triamcinolone—psoriasis	0.000115	0.000693	CcSEcCtD
Clotrimazole—Urticaria—Prednisone—psoriasis	0.000114	0.000691	CcSEcCtD
Clotrimazole—Abdominal pain—Prednisone—psoriasis	0.000114	0.000687	CcSEcCtD
Clotrimazole—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000113	0.00162	CbGpPWpGaD
Clotrimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000113	0.00162	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000113	0.00161	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—IL13—psoriasis	0.000112	0.0016	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism—NDUFA5—psoriasis	0.000109	0.00156	CbGpPWpGaD
Clotrimazole—Nausea—Triamcinolone—psoriasis	0.000108	0.000654	CcSEcCtD
Clotrimazole—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000108	0.00155	CbGpPWpGaD
Clotrimazole—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000106	0.00152	CbGpPWpGaD
Clotrimazole—Vomiting—Dexamethasone—psoriasis	0.000105	0.000635	CcSEcCtD
Clotrimazole—Vomiting—Betamethasone—psoriasis	0.000105	0.000635	CcSEcCtD
Clotrimazole—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000104	0.00149	CbGpPWpGaD
Clotrimazole—Rash—Dexamethasone—psoriasis	0.000104	0.00063	CcSEcCtD
Clotrimazole—Rash—Betamethasone—psoriasis	0.000104	0.00063	CcSEcCtD
Clotrimazole—Dermatitis—Dexamethasone—psoriasis	0.000104	0.000629	CcSEcCtD
Clotrimazole—Dermatitis—Betamethasone—psoriasis	0.000104	0.000629	CcSEcCtD
Clotrimazole—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000104	0.00149	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000103	0.00148	CbGpPWpGaD
Clotrimazole—Pain—Methotrexate—psoriasis	0.000103	0.000621	CcSEcCtD
Clotrimazole—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000102	0.00147	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000102	0.00146	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism—NDUFA5—psoriasis	9.92e-05	0.00142	CbGpPWpGaD
Clotrimazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.85e-05	0.00141	CbGpPWpGaD
Clotrimazole—Nausea—Betamethasone—psoriasis	9.81e-05	0.000593	CcSEcCtD
Clotrimazole—Nausea—Dexamethasone—psoriasis	9.81e-05	0.000593	CcSEcCtD
Clotrimazole—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	9.66e-05	0.00139	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—IL12B—psoriasis	9.57e-05	0.00137	CbGpPWpGaD
Clotrimazole—Urticaria—Methotrexate—psoriasis	9.55e-05	0.000577	CcSEcCtD
Clotrimazole—Abdominal pain—Methotrexate—psoriasis	9.51e-05	0.000574	CcSEcCtD
Clotrimazole—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.34e-05	0.00134	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism—CYP2S1—psoriasis	9.28e-05	0.00133	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism—NDUFA5—psoriasis	9.28e-05	0.00133	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.25e-05	0.00133	CbGpPWpGaD
Clotrimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.2e-05	0.00132	CbGpPWpGaD
Clotrimazole—Vomiting—Prednisone—psoriasis	9.15e-05	0.000553	CcSEcCtD
Clotrimazole—CYP1A2—Tryptophan metabolism—CAT—psoriasis	9.12e-05	0.00131	CbGpPWpGaD
Clotrimazole—Rash—Prednisone—psoriasis	9.07e-05	0.000548	CcSEcCtD
Clotrimazole—Dermatitis—Prednisone—psoriasis	9.06e-05	0.000548	CcSEcCtD
Clotrimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.7e-05	0.00125	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.65e-05	0.00124	CbGpPWpGaD
Clotrimazole—Nausea—Prednisone—psoriasis	8.55e-05	0.000516	CcSEcCtD
Clotrimazole—CYP11A1—Metabolism—NDUFA5—psoriasis	8.49e-05	0.00122	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism—CYP2S1—psoriasis	8.44e-05	0.00121	CbGpPWpGaD
Clotrimazole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.16e-05	0.00117	CbGpPWpGaD
Clotrimazole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.05e-05	0.00115	CbGpPWpGaD
Clotrimazole—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	7.93e-05	0.00114	CbGpPWpGaD
Clotrimazole—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.91e-05	0.00113	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism—CYP2S1—psoriasis	7.89e-05	0.00113	CbGpPWpGaD
Clotrimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.86e-05	0.00113	CbGpPWpGaD
Clotrimazole—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.82e-05	0.00112	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.73e-05	0.00111	CbGpPWpGaD
Clotrimazole—Vomiting—Methotrexate—psoriasis	7.65e-05	0.000462	CcSEcCtD
Clotrimazole—Rash—Methotrexate—psoriasis	7.58e-05	0.000458	CcSEcCtD
Clotrimazole—Dermatitis—Methotrexate—psoriasis	7.57e-05	0.000458	CcSEcCtD
Clotrimazole—CYP11A1—Metabolism—CYP2S1—psoriasis	7.22e-05	0.00103	CbGpPWpGaD
Clotrimazole—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	7.19e-05	0.00103	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism—NDUFA5—psoriasis	7.14e-05	0.00102	CbGpPWpGaD
Clotrimazole—Nausea—Methotrexate—psoriasis	7.14e-05	0.000432	CcSEcCtD
Clotrimazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.04e-05	0.00101	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—IL10—psoriasis	7e-05	0.001	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—IL4—psoriasis	6.81e-05	0.000976	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.66e-05	0.000955	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.66e-05	0.000955	CbGpPWpGaD
Clotrimazole—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.65e-05	0.000953	CbGpPWpGaD
Clotrimazole—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	6.64e-05	0.000952	CbGpPWpGaD
Clotrimazole—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	6.33e-05	0.000908	CbGpPWpGaD
Clotrimazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.2e-05	0.000888	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.17e-05	0.000884	CbGpPWpGaD
Clotrimazole—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	6.09e-05	0.000874	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism—CYP2S1—psoriasis	6.07e-05	0.000871	CbGpPWpGaD
Clotrimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.07e-05	0.00087	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.64e-05	0.000808	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism—NDUFA5—psoriasis	5.62e-05	0.000806	CbGpPWpGaD
Clotrimazole—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	5.26e-05	0.000755	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.24e-05	0.000752	CbGpPWpGaD
Clotrimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	5.06e-05	0.000726	CbGpPWpGaD
Clotrimazole—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	5.02e-05	0.00072	CbGpPWpGaD
Clotrimazole—CYP3A7—Metabolism—NDUFA5—psoriasis	4.88e-05	0.0007	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.86e-05	0.000697	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism—CYP2S1—psoriasis	4.78e-05	0.000685	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism—CARM1—psoriasis	4.53e-05	0.00065	CbGpPWpGaD
Clotrimazole—CYP2A6—Metabolism—NDUFA5—psoriasis	4.47e-05	0.000642	CbGpPWpGaD
Clotrimazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	4.47e-05	0.000641	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.42e-05	0.000634	CbGpPWpGaD
Clotrimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.38e-05	0.000628	CbGpPWpGaD
Clotrimazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	4.31e-05	0.000617	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.24e-05	0.000607	CbGpPWpGaD
Clotrimazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.21e-05	0.000604	CbGpPWpGaD
Clotrimazole—CYP3A7—Metabolism—CYP2S1—psoriasis	4.15e-05	0.000595	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.13e-05	0.000593	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism—CARM1—psoriasis	4.12e-05	0.000591	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—IFNG—psoriasis	4.12e-05	0.00059	CbGpPWpGaD
Clotrimazole—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.11e-05	0.000589	CbGpPWpGaD
Clotrimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	3.91e-05	0.00056	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism—CARM1—psoriasis	3.85e-05	0.000553	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.85e-05	0.000552	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.83e-05	0.000549	CbGpPWpGaD
Clotrimazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.82e-05	0.000548	CbGpPWpGaD
Clotrimazole—CYP2A6—Metabolism—CYP2S1—psoriasis	3.8e-05	0.000546	CbGpPWpGaD
Clotrimazole—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.78e-05	0.000542	CbGpPWpGaD
Clotrimazole—CYP2B6—Metabolism—NDUFA5—psoriasis	3.61e-05	0.000518	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.6e-05	0.000516	CbGpPWpGaD
Clotrimazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.59e-05	0.000515	CbGpPWpGaD
Clotrimazole—CYP2E1—Metabolism—NDUFA5—psoriasis	3.54e-05	0.000507	CbGpPWpGaD
Clotrimazole—CYP11A1—Metabolism—CARM1—psoriasis	3.52e-05	0.000505	CbGpPWpGaD
Clotrimazole—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.29e-05	0.000472	CbGpPWpGaD
Clotrimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.28e-05	0.00047	CbGpPWpGaD
Clotrimazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.28e-05	0.00047	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.18e-05	0.000456	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.15e-05	0.000452	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.11e-05	0.000446	CbGpPWpGaD
Clotrimazole—CYP2B6—Metabolism—CYP2S1—psoriasis	3.07e-05	0.00044	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism—NDUFA5—psoriasis	3.06e-05	0.000438	CbGpPWpGaD
Clotrimazole—CYP2E1—Metabolism—CYP2S1—psoriasis	3.01e-05	0.000431	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism—CARM1—psoriasis	2.97e-05	0.000425	CbGpPWpGaD
Clotrimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	2.95e-05	0.000423	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.85e-05	0.000409	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism—CAT—psoriasis	2.79e-05	0.0004	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.77e-05	0.000398	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism—NDUFA5—psoriasis	2.73e-05	0.000391	CbGpPWpGaD
Clotrimazole—ABCB1—Allograft Rejection—TNF—psoriasis	2.66e-05	0.000382	CbGpPWpGaD
Clotrimazole—ABCB1—Metabolism—NDUFA5—psoriasis	2.66e-05	0.000382	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.65e-05	0.00038	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism—CYP2S1—psoriasis	2.6e-05	0.000373	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.54e-05	0.000365	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism—CAT—psoriasis	2.53e-05	0.000363	CbGpPWpGaD
Clotrimazole—CYP2D6—Metabolism—NDUFA5—psoriasis	2.51e-05	0.00036	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.51e-05	0.000359	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism—NDUFA5—psoriasis	2.49e-05	0.000357	CbGpPWpGaD
Clotrimazole—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.47e-05	0.000355	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism—CAT—psoriasis	2.37e-05	0.00034	CbGpPWpGaD
Clotrimazole—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.36e-05	0.000339	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism—CARM1—psoriasis	2.33e-05	0.000335	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism—CYP2S1—psoriasis	2.32e-05	0.000333	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.32e-05	0.000333	CbGpPWpGaD
Clotrimazole—ABCB1—Metabolism—CYP2S1—psoriasis	2.26e-05	0.000325	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.18e-05	0.000313	CbGpPWpGaD
Clotrimazole—CYP11A1—Metabolism—CAT—psoriasis	2.17e-05	0.000311	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism—APOE—psoriasis	2.17e-05	0.000311	CbGpPWpGaD
Clotrimazole—CYP2D6—Metabolism—CYP2S1—psoriasis	2.13e-05	0.000306	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism—NDUFA5—psoriasis	2.13e-05	0.000305	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism—CYP2S1—psoriasis	2.12e-05	0.000303	CbGpPWpGaD
Clotrimazole—CYP3A7—Metabolism—CARM1—psoriasis	2.03e-05	0.000291	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.98e-05	0.000284	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism—APOE—psoriasis	1.97e-05	0.000282	CbGpPWpGaD
Clotrimazole—CYP51A1—Metabolism—PPARG—psoriasis	1.89e-05	0.00027	CbGpPWpGaD
Clotrimazole—CYP2A6—Metabolism—CARM1—psoriasis	1.86e-05	0.000266	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism—APOE—psoriasis	1.84e-05	0.000264	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism—CAT—psoriasis	1.82e-05	0.000262	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism—CYP2S1—psoriasis	1.81e-05	0.000259	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.76e-05	0.000252	CbGpPWpGaD
Clotrimazole—CYP11B1—Metabolism—PPARG—psoriasis	1.71e-05	0.000246	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.69e-05	0.000242	CbGpPWpGaD
Clotrimazole—CYP11A1—Metabolism—APOE—psoriasis	1.68e-05	0.000242	CbGpPWpGaD
Clotrimazole—CYP3A4—Metabolism—NDUFA5—psoriasis	1.64e-05	0.000235	CbGpPWpGaD
Clotrimazole—CYP17A1—Metabolism—PPARG—psoriasis	1.6e-05	0.00023	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.53e-05	0.00022	CbGpPWpGaD
Clotrimazole—CYP2B6—Metabolism—CARM1—psoriasis	1.5e-05	0.000215	CbGpPWpGaD
Clotrimazole—CYP2E1—Metabolism—CARM1—psoriasis	1.47e-05	0.000211	CbGpPWpGaD
Clotrimazole—CYP11A1—Metabolism—PPARG—psoriasis	1.47e-05	0.00021	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism—CAT—psoriasis	1.44e-05	0.000206	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism—APOE—psoriasis	1.42e-05	0.000203	CbGpPWpGaD
Clotrimazole—CYP3A4—Metabolism—CYP2S1—psoriasis	1.4e-05	0.0002	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.36e-05	0.000195	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.31e-05	0.000188	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism—CARM1—psoriasis	1.27e-05	0.000182	CbGpPWpGaD
Clotrimazole—CYP3A7—Metabolism—CAT—psoriasis	1.25e-05	0.000179	CbGpPWpGaD
Clotrimazole—ABCC3—Metabolism—PPARG—psoriasis	1.23e-05	0.000177	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.000174	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.19e-05	0.00017	CbGpPWpGaD
Clotrimazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.16e-05	0.000166	CbGpPWpGaD
Clotrimazole—CYP2A6—Metabolism—CAT—psoriasis	1.14e-05	0.000164	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism—CARM1—psoriasis	1.13e-05	0.000162	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism—APOE—psoriasis	1.12e-05	0.00016	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.11e-05	0.000159	CbGpPWpGaD
Clotrimazole—ABCB1—Metabolism—CARM1—psoriasis	1.11e-05	0.000159	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.000152	CbGpPWpGaD
Clotrimazole—CYP2D6—Metabolism—CARM1—psoriasis	1.04e-05	0.000149	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism—CARM1—psoriasis	1.03e-05	0.000148	CbGpPWpGaD
Clotrimazole—CYP19A1—Metabolism—PPARG—psoriasis	9.72e-06	0.000139	CbGpPWpGaD
Clotrimazole—CYP3A7—Metabolism—APOE—psoriasis	9.69e-06	0.000139	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.66e-06	0.000138	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.47e-06	0.000136	CbGpPWpGaD
Clotrimazole—CYP2B6—Metabolism—CAT—psoriasis	9.22e-06	0.000132	CbGpPWpGaD
Clotrimazole—CYP2E1—Metabolism—CAT—psoriasis	9.03e-06	0.00013	CbGpPWpGaD
Clotrimazole—CYP2A6—Metabolism—APOE—psoriasis	8.88e-06	0.000127	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism—CARM1—psoriasis	8.83e-06	0.000127	CbGpPWpGaD
Clotrimazole—CYP3A7—Metabolism—PPARG—psoriasis	8.44e-06	0.000121	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.25e-06	0.000118	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism—CAT—psoriasis	7.81e-06	0.000112	CbGpPWpGaD
Clotrimazole—CYP2A6—Metabolism—PPARG—psoriasis	7.74e-06	0.000111	CbGpPWpGaD
Clotrimazole—CYP2B6—Metabolism—APOE—psoriasis	7.17e-06	0.000103	CbGpPWpGaD
Clotrimazole—CYP2E1—Metabolism—APOE—psoriasis	7.02e-06	0.000101	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism—CAT—psoriasis	6.97e-06	9.99e-05	CbGpPWpGaD
Clotrimazole—CYP3A4—Metabolism—CARM1—psoriasis	6.81e-06	9.77e-05	CbGpPWpGaD
Clotrimazole—ABCB1—Metabolism—CAT—psoriasis	6.8e-06	9.75e-05	CbGpPWpGaD
Clotrimazole—CYP2D6—Metabolism—CAT—psoriasis	6.41e-06	9.19e-05	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism—CAT—psoriasis	6.35e-06	9.11e-05	CbGpPWpGaD
Clotrimazole—CYP2B6—Metabolism—PPARG—psoriasis	6.24e-06	8.95e-05	CbGpPWpGaD
Clotrimazole—CYP2E1—Metabolism—PPARG—psoriasis	6.11e-06	8.76e-05	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism—APOE—psoriasis	6.07e-06	8.7e-05	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism—CAT—psoriasis	5.43e-06	7.79e-05	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism—APOE—psoriasis	5.41e-06	7.76e-05	CbGpPWpGaD
Clotrimazole—ABCB1—Metabolism—APOE—psoriasis	5.28e-06	7.58e-05	CbGpPWpGaD
Clotrimazole—CYP2C8—Metabolism—PPARG—psoriasis	5.28e-06	7.58e-05	CbGpPWpGaD
Clotrimazole—CYP2D6—Metabolism—APOE—psoriasis	4.98e-06	7.14e-05	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism—APOE—psoriasis	4.94e-06	7.08e-05	CbGpPWpGaD
Clotrimazole—CYP2C19—Metabolism—PPARG—psoriasis	4.72e-06	6.76e-05	CbGpPWpGaD
Clotrimazole—ABCB1—Metabolism—PPARG—psoriasis	4.6e-06	6.6e-05	CbGpPWpGaD
Clotrimazole—CYP2D6—Metabolism—PPARG—psoriasis	4.34e-06	6.22e-05	CbGpPWpGaD
Clotrimazole—CYP2C9—Metabolism—PPARG—psoriasis	4.3e-06	6.17e-05	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism—APOE—psoriasis	4.22e-06	6.05e-05	CbGpPWpGaD
Clotrimazole—CYP3A4—Metabolism—CAT—psoriasis	4.19e-06	6.01e-05	CbGpPWpGaD
Clotrimazole—CYP1A2—Metabolism—PPARG—psoriasis	3.67e-06	5.27e-05	CbGpPWpGaD
Clotrimazole—CYP3A4—Metabolism—APOE—psoriasis	3.26e-06	4.67e-05	CbGpPWpGaD
Clotrimazole—CYP3A4—Metabolism—PPARG—psoriasis	2.84e-06	4.07e-05	CbGpPWpGaD
